Actinium Pharmaceuticals, Inc. — Form D/A
Actinium Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2014-01-21. The offering totals $6.6M, of which $6.6M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2014-01-21
- Form: D/A
- Accession: 0001213900-14-000347
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $6.6M
- Amount sold: $6.6M
- Minimum investment: $5K
- Investors: 63
- Date of first sale: 2013-12-27
- Security types: equity
- Revenue range: No Revenues
- SEC file number: 021-209458
Issuer
- Name: Actinium Pharmaceuticals, Inc.
- CIK: 0001388320
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 501 FIFTH AVENUE, NEW YORK, NY, 10017
- Phone: (646)459-4201
Officers, directors & promoters (12)
| Name | Role | Location |
|---|
| Kaushik J Dave | Director | New York, NY |
| David J Nicholson | Director | New York, NY |
| Sandesh J Seth | Director | New York, NY |
| Richard I Steinhart | Director | New York, NY |
| Sergio J Traversa | Director | New York, NY |
| Dragan J Cicic | Executive Officer | New York, NY |
| Kaushik J Dave | Executive Officer | New York, NY |
| Sergio J Traversa | Executive Officer | New York, NY |
| Sergio V Traversa | Director | New York, NY |
| Sergio V Traversa | Executive Officer | New York, NY |
| Jack V Talley | Director | New York, NY |
| Jack V Talley | Executive Officer | New York, NY |
Other filings by this issuer (5)
More